Industry reports
Editor highlights

US Vaccines Market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Anesthetic Conduction Catheters - Medical Device Safety and Approval Report - Comprehensive

Anesthetic Conduction Catheters - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • by DeviceMatters
  • April 2014
  • 58 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Anesthetic Conduction Catheters, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 745kb pdf report is ...

Industries: Drug and Medication | Countries: United States

Parathyroid Hormone Radioimmunoassays - Medical Device Safety and Approval Report - Comprehensive

Parathyroid Hormone Radioimmunoassays - Medical Device Safety and Approval Report - Comprehensive

  • $ 149
  • Industry report
  • by DeviceMatters
  • April 2014
  • 70 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Parathyroid Hormone Radioimmunoassays, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 798kb pdf report ...

Industries: Drug and Medication | Countries: United States

Oncology Drug Pathway Analyzer (Standard Version)

Oncology Drug Pathway Analyzer (Standard Version)

  • $ 10 350
  • Industry report
  • by Bioseeker
  • March 2014

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool ...

Industries: Drug and Medication | Countries: United States

Oncology Drug Pathway Analyzer (Premium Version)

Oncology Drug Pathway Analyzer (Premium Version)

  • $ 14 850
  • Industry report
  • by Bioseeker
  • March 2014

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool ...

Industries: Drug and Medication | Countries: United States

Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2014

Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • by Bioseeker
  • March 2014

The US Food and Drug Administration (FDA) has throughout the last decades added four major ways it can speed up the market approval of new drugs, ranging from Fast track (1988), Accelerated approval (1992), Priority review (1992) to the most recent Breakthrough therapy (2012). This pipeline update, Cance ...

Industries: Drug and Medication | Countries: United States

CytRx Corporation (CYTR) - Financial and Strategic SWOT Analysis Review

CytRx Corporation (CYTR) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • March 2014
  • 43 pages

CytRx Corporation (CYTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and ...

Industries: Drug and Medication | Countries: United States

Celsion Corporation (CLSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celsion Corporation (CLSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 63 pages

Summary Celsion Corporation (Celsion) is a late-stage biopharmaceutical company, which develops innovative cancer drugs. It undertakes the development and commercialization of novel tumor-targeting treatments utilizing focused heat energy along with heat-activated liposomal drug technology. The company's ...

Industries: Drug and Medication | Countries: United States

Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 376 pages

Summary Johnson & Johnson (J&J) is a holding company. It carries out the research and development, manufacture and sale of a wide range of pharmaceutical and medical products. It provides products for human health and well-being. J&J's product offerings include Consumer products; Pharmaceuticals; and ...

Industries: Drug and Medication | Countries: United States

BioDelivery Sciences International, Inc. (BDSI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioDelivery Sciences International, Inc. (BDSI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 33 pages

Summary BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company. The company develops and commercializes products in the areas of pain management and oncology supportive care, including chronic pain, breakthrough cancer pain, opioid dependence, and nausea and vomiting related ...

Industries: Drug and Medication | Countries: United States

United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 120 pages

BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceutical market. This is in stark contrast to the late 1990s and early 2000s, when the business environment was relatively insulated from external factors and drugmakers consistently recorded double-digit growth. ...

Industries: Drug and Medication | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.